These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 27829151)

  • 1. A Genetic Screen Identifies Hypothalamic Fgf15 as a Regulator of Glucagon Secretion.
    Picard A; Soyer J; Berney X; Tarussio D; Quenneville S; Jan M; Grouzmann E; Burdet F; Ibberson M; Thorens B
    Cell Rep; 2016 Nov; 17(7):1795-1806. PubMed ID: 27829151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fgf15 Neurons of the Dorsomedial Hypothalamus Control Glucagon Secretion and Hepatic Gluconeogenesis.
    Picard A; Metref S; Tarussio D; Dolci W; Berney X; Croizier S; Labouebe G; Thorens B
    Diabetes; 2021 Jul; 70(7):1443-1457. PubMed ID: 33883213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypothalamic Irak4 is a genetically controlled regulator of hypoglycemia-induced glucagon secretion.
    Picard A; Berney X; Castillo-Armengol J; Tarussio D; Jan M; Sanchez-Archidona AR; Croizier S; Thorens B
    Mol Metab; 2022 Jul; 61():101479. PubMed ID: 35339728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A gut-brain axis regulating glucose metabolism mediated by bile acids and competitive fibroblast growth factor actions at the hypothalamus.
    Liu S; Marcelin G; Blouet C; Jeong JH; Jo YH; Schwartz GJ; Chua S
    Mol Metab; 2018 Feb; 8():37-50. PubMed ID: 29290621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of hypothalamic adenosine 5'-monophosphate-activated protein kinase in the impaired counterregulatory response induced by repetitive neuroglucopenia.
    Alquier T; Kawashima J; Tsuji Y; Kahn BB
    Endocrinology; 2007 Mar; 148(3):1367-75. PubMed ID: 17185376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ca2+/calmodulin-dependent protein kinase kinase is not involved in hypothalamic AMP-activated protein kinase activation by neuroglucopenia.
    Kawashima J; Alquier T; Tsuji Y; Peroni OD; Kahn BB
    PLoS One; 2012; 7(5):e36335. PubMed ID: 22590531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the control of glucagon secretion by the parasympathetic nervous system in man.
    Palmer JP; Werner PL; Hollander P; Ensinck JW
    Metabolism; 1979 May; 28(5):549-52. PubMed ID: 449696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disrupted hypothalamic transcriptomics and proteomics in a mouse model of type 2 diabetes exposed to recurrent hypoglycaemia.
    Castillo-Armengol J; Marzetta F; Rodriguez Sanchez-Archidona A; Fledelius C; Evans M; McNeilly A; McCrimmon RJ; Ibberson M; Thorens B
    Diabetologia; 2024 Feb; 67(2):371-391. PubMed ID: 38017352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disrupted Leptin Signaling in the Lateral Hypothalamus and Ventral Premammillary Nucleus Alters Insulin and Glucagon Secretion and Protects Against Diet-Induced Obesity.
    Denroche HC; Glavas MM; Tudurí E; Karunakaran S; Quong WL; Philippe M; Britton HM; Clee SM; Kieffer TJ
    Endocrinology; 2016 Jul; 157(7):2671-85. PubMed ID: 27183315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid biosynthesis enzyme Agpat5 in AgRP-neurons is required for insulin-induced hypoglycemia sensing and glucagon secretion.
    Strembitska A; Labouèbe G; Picard A; Berney XP; Tarussio D; Jan M; Thorens B
    Nat Commun; 2022 Sep; 13(1):5761. PubMed ID: 36180454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential receptor selectivity of the FGF15/FGF19 orthologues determines distinct metabolic activities in
    Hansen AMK; Vienberg SG; Lykkegaard K; Zhao X; Tingqing G; Han D; Zhang X; Thøgersen H; Sass-Ørum K; Tagmose T; Raun K; Andersen B
    Biochem J; 2018 Sep; 475(18):2985-2996. PubMed ID: 30127091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse species-specific control of hepatocarcinogenesis and metabolism by FGF19/FGF15.
    Zhou M; Luo J; Chen M; Yang H; Learned RM; DePaoli AM; Tian H; Ling L
    J Hepatol; 2017 Jun; 66(6):1182-1192. PubMed ID: 28189755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex-Specific Control of Fat Mass and Counterregulation by Hypothalamic Glucokinase.
    Steinbusch LK; Picard A; Bonnet MS; Basco D; Labouèbe G; Thorens B
    Diabetes; 2016 Oct; 65(10):2920-31. PubMed ID: 27422385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neural control of pancreatic peptide hormone secretion.
    Verberne AJM; Mussa BM
    Peptides; 2022 Jun; 152():170768. PubMed ID: 35189258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tmem117 in AVP neurons regulates the counterregulatory response to hypoglycemia.
    Gaspari S; Labouèbe G; Picard A; Berney X; Rodriguez Sanchez-Archidona A; Thorens B
    EMBO Rep; 2023 Aug; 24(8):e57344. PubMed ID: 37314252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoglycemia-activated GLUT2 neurons of the nucleus tractus solitarius stimulate vagal activity and glucagon secretion.
    Lamy CM; Sanno H; Labouèbe G; Picard A; Magnan C; Chatton JY; Thorens B
    Cell Metab; 2014 Mar; 19(3):527-38. PubMed ID: 24606905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse FGF15 is the ortholog of human and chick FGF19, but is not uniquely required for otic induction.
    Wright TJ; Ladher R; McWhirter J; Murre C; Schoenwolf GC; Mansour SL
    Dev Biol; 2004 May; 269(1):264-75. PubMed ID: 15081372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monomeric/dimeric forms of Fgf15/FGF19 show differential activity in hepatocyte proliferation and metabolic function.
    Williams CM; Harper Calderon J; E H; Jimenez Y; Barringer K; Carbonaro M; Molina-Portela MDP; Thurston G; Li Z; Daly C
    FASEB J; 2021 Feb; 35(2):e21286. PubMed ID: 33484478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypothalamic POMC or MC4R deficiency impairs counterregulatory responses to hypoglycemia in mice.
    Tooke BP; Yu H; Adams JM; Jones GL; Sutton-Kennedy T; Mundada L; Qi NR; Low MJ; Chhabra KH
    Mol Metab; 2019 Feb; 20():194-204. PubMed ID: 30503832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. I.c.v. administration of the nonsteroidal glucocorticoid receptor antagonist, CP-472555, prevents exacerbated hypoglycemia during repeated insulin administration.
    Kale AY; Paranjape SA; Briski KP
    Neuroscience; 2006 Jun; 140(2):555-65. PubMed ID: 16626867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.